China Resources Boya Bio pharmaceutical Group Co Ltd banner

China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294

Watchlist Manager
China Resources Boya Bio pharmaceutical Group Co Ltd Logo
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
Watchlist
Price: 19.11 CNY -0.05% Market Closed
Market Cap: ¥9.6B

Wall Street
Price Targets

Price Targets Summary
China Resources Boya Bio pharmaceutical Group Co Ltd

Wall Street analysts forecast China Resources Boya Bio pharmaceutical Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for China Resources Boya Bio pharmaceutical Group Co Ltd is 31.78 CNY with a low forecast of 28.28 CNY and a high forecast of 36.75 CNY.

Lowest
Price Target
28.28 CNY
48% Upside
Average
Price Target
31.78 CNY
66% Upside
Highest
Price Target
36.75 CNY
92% Upside
China Resources Boya Bio pharmaceutical Group Co Ltd Competitors:
Price Targets
CASY
Caseys General Stores Inc
-1% Downside
EXPO
Exponent Inc
34% Upside

Revenue
Forecast

18% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
18% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

For the last 14 years the compound annual growth rate for China Resources Boya Bio pharmaceutical Group Co Ltd's revenue is 18%. The projected CAGR for the next 2 years is 10%.

Operating Income
Forecast

11% / Year
Past Growth
55% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss
11% / Year
Past Growth
55% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss

For the last 14 years the compound annual growth rate for China Resources Boya Bio pharmaceutical Group Co Ltd's operating income is 11%. The projected CAGR for the next 3 years is 55%.

Net Income
Forecast

4% / Year
Past Growth
148% / Year
Estimated Growth
Estimates Accuracy
-27%
Average Miss
4% / Year
Past Growth
148% / Year
Estimated Growth
Estimates Accuracy
-27%
Average Miss

For the last 14 years the compound annual growth rate for China Resources Boya Bio pharmaceutical Group Co Ltd's net income is 4%. The projected CAGR for the next 2 years is 148%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is China Resources Boya Bio pharmaceutical Group Co Ltd's stock price target?
Price Target
31.78 CNY

According to Wall Street analysts, the average 1-year price target for China Resources Boya Bio pharmaceutical Group Co Ltd is 31.78 CNY with a low forecast of 28.28 CNY and a high forecast of 36.75 CNY.

What is China Resources Boya Bio pharmaceutical Group Co Ltd's Revenue forecast?
Projected CAGR
10%

For the last 14 years the compound annual growth rate for China Resources Boya Bio pharmaceutical Group Co Ltd's revenue is 18%. The projected CAGR for the next 2 years is 10%.

What is China Resources Boya Bio pharmaceutical Group Co Ltd's Operating Income forecast?
Projected CAGR
55%

For the last 14 years the compound annual growth rate for China Resources Boya Bio pharmaceutical Group Co Ltd's operating income is 11%. The projected CAGR for the next 3 years is 55%.

What is China Resources Boya Bio pharmaceutical Group Co Ltd's Net Income forecast?
Projected CAGR
148%

For the last 14 years the compound annual growth rate for China Resources Boya Bio pharmaceutical Group Co Ltd's net income is 4%. The projected CAGR for the next 2 years is 148%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett